It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Researchers at the University of Oxford have today reported that the risk of the rare blood clotting known as cerebral venous thrombosis (CVT) following COVID-19 infection is around 100 times greater than normal, several times higher than it is post-vaccination or following influenza.
AstraZeneca and the University of Oxford today announced an agreement for the global development and distribution of the University’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2.
COVID-19 patients face a much higher risk of developing blood clots than those vaccinated with AstraZeneca or Pfizer shots
The Oxford vaccine – developed in partnership with AstraZeneca – stops 70% of people developing COVID symptoms. And, depending on how the doses are given, may even protect up to 90% of people. This follows recent announcements from Pfizer and from Moderna that their vaccines provide greater than 90% efficacy.
CALGARY, Alberta, May 11 (Reuters) - The Canadian provinces of Alberta and Ontario said on Tuesday they would stop offering first doses of AstraZeneca's COVID-19 vaccine, with Ontario citing evidence that the risk of rare blood clots is somewhat higher than previously estimated.
originally posted by: amazingexplorer
……. I bet the new Delta variant produces far less blood clot than the original strain, considering the new Delta variant is highly attenuated and produces symptoms very close to common cold symptoms.
originally posted by: 1947boomer
originally posted by: amazingexplorer
……. I bet the new Delta variant produces far less blood clot than the original strain, considering the new Delta variant is highly attenuated and produces symptoms very close to common cold symptoms.
What in the world makes you think the Delta variant is attenuated?
www.cdc.gov...
“ The Delta variant is highly contagious, more than 2x as contagious as previous variants.”
The messenger protein in the vaccine has to alter the DNA of a cell to make it produce a spike
Once in the cell, it enters the microconidia and gives it the information.
I don't see where it says that but according to whom is it false? Has the vaccine been detected in other locations?
It says in this instruction manual that the injection stays at the injection site, this is false.